Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
about
miR-19b downregulates intestinal SOCS3 to reduce intestinal inflammation in Crohn's diseaseSTAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.Intestinal epithelial suppressor of cytokine signaling 3 (SOCS3) impacts on mucosal homeostasis in a model of chronic inflammation.Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis.
P2860
Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Increased suppressor of cytoki ...... relapse in ulcerative colitis.
@en
Increased suppressor of cytoki ...... relapse in ulcerative colitis.
@nl
type
label
Increased suppressor of cytoki ...... relapse in ulcerative colitis.
@en
Increased suppressor of cytoki ...... relapse in ulcerative colitis.
@nl
prefLabel
Increased suppressor of cytoki ...... relapse in ulcerative colitis.
@en
Increased suppressor of cytoki ...... relapse in ulcerative colitis.
@nl
P2093
P2860
P356
P1476
Increased suppressor of cytoki ...... relapse in ulcerative colitis.
@en
P2093
C Janneke van der Woude
Colin de Haar
Judith E Baars
Katharina Biermann
Veerle J A A Nuij
P2860
P304
P356
10.1002/IBD.22992
P577
2013-01-01T00:00:00Z